Iguratimod Inhibits the Aggressiveness of Rheumatoid Fibroblast-Like Synoviocytes

OBJECTIVE: Iguratimod, a novel disease-modifying anti-rheumatic drug for the treatment of rheumatoid arthritis, has been approved in China and Japan. Here, we aimed to find whether iguratimod can inhibit the aggressive behavior and promote apoptosis of rheumatoid fibroblast-like synoviocytes (RA-FLS...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Jin, Yu, Ye, Wang, Xuanwei, Ke, Yini, Sun, Chuanyin, Yue, Lihuan, Xu, Guanhua, Xu, Bei, Xu, Liqin, Cao, Heng, Xu, Danyi, Olsen, Nancy, Chen, Weiqian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885276/
https://www.ncbi.nlm.nih.gov/pubmed/31828173
http://dx.doi.org/10.1155/2019/6929286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885276/
https://www.ncbi.nlm.nih.gov/pubmed/31828173
http://dx.doi.org/10.1155/2019/6929286

Ejemplares similares